A Quiet Life with Proteins*

Literature Cited

1. Amit AG, Mariuzza RA, Phillips SE, Poljak RJ. 1986. Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233:747–53 [Google Scholar]
2. Bell JK, Mullen GED, Leifer CA, Mazzoni A, Davies DR, Segal DM. 2003. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24:528–33 [Google Scholar]
3. Cochran W. 1952. A relation between the signs of structure factors. Acta Crystallogr 5:65–67 [Google Scholar]
4. Cochran W, Crick FHC, Vand V. 1952. The structure of synthetic polypeptides. 1. The transform of atoms on a helix. Acta Crystallogr 5:581–86 [Google Scholar]
5. Crick FHC, Davies DR, Rich A, Watson JD. 1961. The molecular structure of polyadenylic acid. J. Mol. Biol 3:71–86 [Google Scholar]
6. Daopin S, Piez KA, Ogawa Y, Davies DR. 1992. Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science 257:369–73 [Google Scholar]
7. Davies DR. 1960. Polyinosinic plus polycytidylic acid: a crystalline polynucleotide complex. Nature 196:1030–31 [Google Scholar]
8. Davies DR, Blum JJ. 1955. The crystal structure of parabanic acid. Acta Crystallogr. 8:129–36 [Google Scholar]
9. Davies DR, Pasternak R. 1956. A refinement of the crystal structure of succinamide. Acta Crystallogr. 9:334–40 [Google Scholar]
10. Davis BD. 1958. On the importance of being ionized. Arch. Biochem. Biophys 78:497–509 [Google Scholar]
11. Dyda F, Hickman A, Jenkins T, Engelman A, Craigie R, Davies DR. 1994. Crystal structure of the catalytic domain of HIV-1 integrase reveals similarity with other polynucleotidyl transferases. Science 266:1981–86 [Google Scholar]
12. Felsenfeld G, Davies DR, Rich A. 1957. Formation of a three-stranded polynucleotide molecule. J. Am. Chem. Soc. 79:2023–24 [Google Scholar]
13. Gellert M, Lipsett MN, Davies DR. 1962. Helix formation by guanylic acid. Proc. Natl. Acad. Sci. USA 48:2013–18 [Google Scholar]
14. Goldgur Y, Craigie R, Cohen GH, Fujiwara T, Yoshinaga T. et al. 1999. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA 96:13040–43 [Google Scholar]
15. Goldgur Y, Dyda F, Hickman AB, Jenkins TM, Craigie R, Davies DR. 1998. Three additional structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA 95:9150–54 [Google Scholar]
16. Hauptman H, Karle J. 1952. Crystal-structure determination by means of a statistical distribution of interatomic vectors. Acta Crystallogr. 5:48–59 [Google Scholar]
17. Hyde CD, Padlan EA, Ahmed SA, Miles EW, Davies DR. 1988. Three-dimensional structure of the tryptophan synthase multienzyme complex from Salmonella typhimurium. J. Biol. Chem. 263:17857–71 [Google Scholar]
18. Kendrew JC, Dickerson RE, Strandberg BE, Hart RG, Davies DR. et al. 1960. Structure of myoglobin. Nature 185:422–27 [Google Scholar]
19. Li M, Dyda F, Benhar I, Pastan I, Davies DR. 1995. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin. Proc. Natl. Acad. Sci. USA 92:9308–12 [Google Scholar]
20. Li M, Dyda F, Benhar I, Pastan I, Davies DR. 1996. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation. Proc. Natl. Acad. Sci. USA 93:6902–06 [Google Scholar]
21. Liao DI, Silverton E, Seok YJ, Lee BR, Peterkofsky A, Davies DR. 1996. The first step in sugar transport: crystal structure of the amino terminal domain of enzyme I of the E. coli PEP: sugar phosphotransferase system and a model of the phosphotransferase complex with Hpr. Structure 4:861–72 [Google Scholar]
22. Liao DI, Wolff E, Park MH, Davies DR. 1998. Crystal structure of the NAD complex of human deoxyhypusine synthase: an enzyme with a ball and chain mechanism for blocking the active site. Structure 6:23–32 [Google Scholar]
23. Matthews BW. 1968. Solvent content of protein crystals. J. Mol. Biol. 33:491–97 [Google Scholar]
24. Miles E, Rhee S, Davies DR. 1999. The molecular basis of substrate channeling. J. Biol. Chem. 274:12193–96 [Google Scholar]
25. Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, Davies DR. 1989. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab lysozyme complex. Proc. Natl. Acad. Sci. USA 86:5938–42 [Google Scholar]
26. Rich A, Davies DR. 1956. A new two-stranded helical structure: polyadenylic acid and polyuridylic acid. J. Am. Chem. Soc 78:3548–49 [Google Scholar]
27. Rhee S, Han Z-J, Liu K, Miles HT, Davies DR. 1999. Structure of a triple helical DNA with a triplex-duplex junction. Biochemistry 38:16810–15 [Google Scholar]
28. Rhee S, Martin RG, Rosner JL, Davies DR. 1998. A novel DNA-binding motif of MarA: the first structure for an AraC family transcriptional activator. Proc. Natl. Acad. Sci. USA 95:10413–18 [Google Scholar]
29. Rhee S, Parris KD, Ahmed SA, Miles EW, Davies DR. 1996. Exchange of K⁺ or Cs⁺ for Na⁺ induces local and long-range changes in the three-dimensional structure of the tryptophan synthase α₂β₂ complex. Biochemistry 35:4211–21 [Google Scholar]
30. Sarma VR, Davies DR, Labaw LW, Silverton EW, Terry WD. 1971. Crystal structure of an immunoglobulin molecule by X-ray diffraction and electron microscopy. Cold Spring Harbor Symp. Quant. Biol. XXXVI:413–19 [Google Scholar]
31. Sayre D. 1952. The squaring method: a new method for phase determination. Acta Crystallogr. 5:60–65 [Google Scholar]
32. Segal DM, Padlan EA, Cohen GH, Rudikoff S, Potter M, Davies DR. 1974. The three-dimensional structure of a phosphorylcholine binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA 71:4298–302 [Google Scholar]
33. Segal DM, Power JC, Cohen GH, Davies DR, Wilcox PE. 1971. The substrate binding site in bovine chymotrypsin AR: a crystallographic study using peptide chloromethyl ketones as site specific inhibitors. Biochemistry 10:3728–37 [Google Scholar]
34. Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ. et al. 1987. Three-dimensional structure of an antibody-antigen complex. Proc. Natl. Acad. Sci. USA 84:8075–79 [Google Scholar]
35. Sigler PB, Skinner HCW, Coulter CL, Kallos J, Braxton H, Davies DR. 1964. An isomorphous heavy atom substitution at the active site of gamma-chymotrypsin. Proc. Natl. Acad. Sci. USA 51:1146–51 [Google Scholar]
36. Subramanian E, Swan IDA, Liu M, Davies DR, Jenkins JA. et al. 1977. Homology among acid proteases: comparison of crystal structure at 3 Å resolution of acid proteases from Rhizopus chinensis and Endothia parasitica. Proc. Natl. Acad. Sci. USA 74:556–59 [Google Scholar]
37. Suguna K, Bott RR, Padlan EA, Subramanian E, Sheriff S. et al. 1987. Structure and refinement at 1.8 Å resolution of the aspartic proteinase from Rhizopus chinensis. J. Mol. Biol. 196:877–900 [Google Scholar]
38. Suguna K, Padlan EA, Smith CW, Carlson WD, Davies DR. 1987. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. Proc. Natl. Acad. Sci. USA 84:7009–13 [Google Scholar]
39. Terry WD, Matthews BW, Davies DR. 1968. Crystallographic studies of a human immunoglobulin. Nature 220:239–41 [Google Scholar]
40. Umland TC, Taylor KL, Rhee S, Wickner RB, Davies DR. 2001. The crystal structure of the nitrogen regulation fragment of the yeast prion protein Ure2p. Proc. Natl. Acad. Sci. USA 98:1459–64 [Google Scholar]
41. Umland TC, Wolff EC, Park MH, Davies DR. 2004. A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme-NAD-inhibitor ternary complex. J. Biol. Chem 279:28697–705 [Google Scholar]
42. Zachariasen WH. 1952. A new analytical method for solving complex crystal structures. Acta Crystallogr 5:68–73 [Google Scholar]